Western CDMOs say around-time period stewardship on the pharmaceutical offer chain is likely to call for them to repurpose output lines to manufacture medicines and raw materials critical to battling the new coronavirus.The process qualification period includes an assessment of if the method is reproducible. There are 2 key factors to procedure qua